Pam Belluck Profile Banner
Pam Belluck Profile
Pam Belluck

@PamBelluck

Followers
9,825
Following
993
Media
121
Statuses
7,201

New York Times writer covering health & science. Author of "Island Practice," a book about a quirky island doctor. Jazz flutist. Lapsed Ultimate Frisbee player.

Joined December 2009
Don't wanna be here? Send us removal request.
Pam Belluck Retweeted
@EricTopol
Eric Topol
a day ago
From the large insurer report of >1.9 million people with covid, a large proportion were asymptomatic and nearly 1 in 5 of them had symptoms 1-month post covid diagnosis https://t.co/NPTqGn4hYX https://t.co/4rJEX7sKEQ by @PamBelluck https://t.co/DJh7u6MgZ7
Tweet media one
Tweet media two
5
50
93
Pam Belluck Retweeted
@hmkyale
Harlan Krumholz
a day ago
From an insurance claims report of #LongCOVID … 'Of patients who had COVID-19, 23.2% had at least one post-COVID condition.’ Reported by @PamBelluck @nytimes https://t.co/rsK8QZBcM9 https://t.co/coCt61stdu https://t.co/PppiJAFPLx
Tweet media one
1
5
3
@PamBelluck
Pam Belluck
a day ago
Still, it seems to be the largest so far looking at post-Covid health issues. It underscores, says @zalaly, that "people with long Covid need multidisciplinary care and our health systems should adapt to this reality and develop capacity to deal with these patients."3/3
1
4
11
@PamBelluck
Pam Belluck
a day ago
The study has limitations, including: it only uses private health insurance records, no control group to allow comparison to people who didn't have Covid, no data on when symptoms arose or how long problems persisted, diagnostic codes can miss or miscategorize symptoms. 2/3
1
0
3
Pam Belluck Retweeted
@NYTHealth
NYT Health
3 days ago
As the pandemic eases, the F.D.A. is trying to catch up on inspections, reviews of cell and gene therapies, and other work delayed due to Covid.  https://t.co/yx3g5QhMXF
1
2
2
Pam Belluck Retweeted
@NYTScience
NYT Science
3 days ago
In approving Biogen's controversial Alzheimer's drug this week, the F.D.A. overruled the objections of its independent advisers. Now, three of those advisers have resigned. https://t.co/RqldSLhPFY
0
14
11
@PamBelluck
Pam Belluck
3 days ago
Thank you so much! I really appreciate this very kind comment! https://t.co/Umvh0DhLhb
@ellenlebowitz
Ellen Lebowitz
4 days ago
Read this story about the the new drug for Alzheimer's, and, every other story @Pam Belluck writes. Her research and writing are both remarkable. https://t.co/I1j6mJje9Q
0
0
2
Pam Belluck Retweeted
@ceciliakang
Cecilia Kang 강 미선
4 days ago
what a public service it was and still is incredibly proud of this newsroom https://t.co/vGKIvlGtdg
@nytimes
The New York Times
4 days ago
The staff of The New York Times has won the Pulitzer Prize for Public Service for coverage of the pandemic. Here are the award-winning pieces. https://t.co/ghMdQs0W4J https://t.co/2HfAc7E48S
Tweet media one
0
5
43
@PamBelluck
Pam Belluck
4 days ago
Enjoyed talking with @johndankosky on @scifri about the controversial approval of the new drug for Alzheimer's disease https://t.co/RgvTwXpSsF
@scifri
Science Friday
4 days ago
This week, the FDA approved the new Alzheimer's drug aducanumab, but it’s unclear if the costly treatment actually leads to improved cognition and memory in people with the disease. @NYtimes's reporter @PamBelluck shares more on #SciFriLive📻. https://t.co/v8ILc5Er9x
0
3
8
@PamBelluck
Pam Belluck
4 days ago
Thank you! Honored to contribute to the NYT's Covid coverage with my wonderful colleagues! https://t.co/vlRa93ZgVx
@fredguterl
Fred Guterl
4 days ago
Huge congrats to @apoorva_nyc @carlzimmer @PamBelluck and the rest of the NYT covid team. Also: thanks https://t.co/YnEljnx8zU
1
1
4
Pam Belluck Retweeted
@nytimes
The New York Times
4 days ago
The staff of The New York Times has won the Pulitzer Prize for Public Service for coverage of the pandemic. Here are the award-winning pieces. https://t.co/ghMdQs0W4J https://t.co/2HfAc7E48S
Tweet media one
236
774
4K
Pam Belluck Retweeted
@NYTHealth
NYT Health
5 days ago
In approving Biogen's controversial Alzheimer's drug this week, the F.D.A. overruled the objections of its independent advisers. Now, three of those advisers have resigned. https://t.co/TUZzl72VDD
1
10
7
Pam Belluck Retweeted
@pash22
Ash Paul
5 days ago
Three @US_FDA Advisers Resign Over Agency’s Approval of Alzheimer’s Drug: The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients. https://t.co/n7s3nQ3cCG via @PamBelluck & @RebeccaDRobbins
5
15
23
Pam Belluck Retweeted
@RebeccaDRobbins
Rebecca Robbins
5 days ago
The FDA's approval of $BIIB's Aduhelm is spurring major backlash in the scientific community — most notably, with the resignations of 3 advisers to the agency. The question now is whether lawmakers, payers and patients will balk. With @PamBelluck: https://t.co/DSzzLiNBtG
10
44
82